Keywords: novo, nordisk, posts, solid, first-quarter, sales, denmark
Novo Nordisk posts solid first-quarter sales
Article | 13 May 1999
Denmark's Novo Nordisk has posted an 11% rise in consolidated sales forthe first quarter of 1999, up to 4.65 billion Danish kroner ($675.2 million), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
